Search


Canada Guidance: Regulatory Enrolment Process (REP)
Yesterday (29-September 2022) Health Canada updated their guidance on Regulatory Enrolment Process (REP). Health Canada's Regulatory...

Sharan Murugan
Sep 30, 20221 min read
Â
Â


EMA Guidance: Checking process of Mock-ups & Specimens of Outer/Immediate Labelling & PI -CP
Earlier on 27th Spetmber, 2022 EMA revised and released their updated Regulatory and procedural guideline on "Checking process of...

Sharan Murugan
Sep 30, 20222 min read
Â
Â


UK MHRA: European Commission Decision Reliance Procedure (EC DRP) Extension
Earlier today (30 September 2022) to ensure British people have timely access to medicines, the European Commission Decision Reliance...

Sharan Murugan
Sep 30, 20221 min read
Â
Â


EMA Guidance: Good Practice Guide for the use of the Metadata Catalogue of Real-World Data Sources
Earlier today (27-September-2022) EMA released draft guidance on the "Good Practice Guide for the use of the Metadata Catalogue of...

Sharan Murugan
Sep 27, 20221 min read
Â
Â


MHRA Guidance: Good Clinical Practice for Clinical Trials
Earlier today (27 September 2022) MHRA released updated guidance on Good clinical practice for Clinical Trials where they had updated...

Sharan Murugan
Sep 27, 20221 min read
Â
Â


USFDA Guidance: Clinical Investigations of Medical Products Involving Children
A draft guidance was released on 23 September 2022 by the US Food and Drug Administration on the ethical considerations for including and...

Sharan Murugan
Sep 25, 20221 min read
Â
Â


USFDA Guidance: Distribution of Approved Naloxone Products -Immediately-in-Effect
Yesterday (22 September 2022) USFDA issued “Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act...

Sharan Murugan
Sep 23, 20221 min read
Â
Â


Artificial Intelligence in Regulatory Affairs
Artificial Intelligence (AI) is a broad term that encompasses many different things and is a kind of intelligence that is created by a...

Sharan Murugan
Sep 21, 20223 min read
Â
Â


UK MHRA Guidance: The Northern Ireland MHRA Authorised Route (NIMAR)
The UK MHRA released this updated guidance today and added a section on 'Advertising and promotions' to Northern Ireland MHRA Authorised...

Sharan Murugan
Sep 20, 20221 min read
Â
Â


USFDA Guide: Updated eCTD 4.0 - TECHNICAL CONFORMANCE GUIDE,
Recently USFDA released an updated "Electronic Common Technical Document (eCTD) Technical Conformance Guide" that revised some sections...

Sharan Murugan
Sep 17, 20221 min read
Â
Â


Swissmedic Guidance: eDok Submission Update
Swissmedic on Thursday released an updated guidance document on the eDok submission which as included new templates with minor other...

Sharan Murugan
Sep 17, 20221 min read
Â
Â


ICH Guidance: Q3D(R2) ELEMENTAL IMPURITIES
Recently the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) released the...

Sharan Murugan
Sep 17, 20221 min read
Â
Â


Indian Pharmacopoeia Commission (IPC) Joins Pharmacopoeial Discussion Group for Global Expansion
Recently the Pharmacopoeial Discussion Group (PDG), which comprises the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia...

Sharan Murugan
Sep 14, 20221 min read
Â
Â


USFDA: Annual Summary Reporting Requirements -Right to Try Act -Final Rule
In yesterday's final rule, the U.S. Food and Drug Administration outlined (Unpublished version) the requirements for annual reports by...

Sharan Murugan
Sep 14, 20221 min read
Â
Â


Health Canada: Udated Register of Innovative Drugs
The Register of Innovative Drugs is maintained pursuant to subsection C.08.004.1(9) of the Food and Drug Regulations of Health Canada and...

Sharan Murugan
Sep 14, 20221 min read
Â
Â


USFDA Guidance: Submitting Documents Using Real-World Data & RW Evidence for Drug & Biologics
Earlier today (08-September-2022) USFDA's Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research...

Sharan Murugan
Sep 8, 20221 min read
Â
Â


USFDA Guidance: Content & Format of Labeling for Non-Prescription Drugs, Quantitative Labeling
Earlier today on 8-September-2022, USFDA's Center for Drug Evaluation and Research, Office of New Drugs published two draft Labeling...

Sharan Murugan
Sep 8, 20222 min read
Â
Â


USFDA Guidance: Clinical Pharmacology Considerations for Pediatric Studies of Drugs & Biologics
Yesterday 07-September-2022, USFDA's Center for Drug Evaluation and Research published a draft guideline "General Clinical Pharmacology...

Sharan Murugan
Sep 8, 20221 min read
Â
Â


IRIS Updated Guide: How to Create & Submit Scientific Applications & Accelerating Clin. Trials Plan
On 2-September, 2022 the European Medicines Agency released the updated IRIS guidance on "How to create and submit scientific...

Sharan Murugan
Sep 4, 20221 min read
Â
Â


Singapore HSA: Safety Alert for Finasteride and Potential Risk of Suicidal iIdeation
The Singapore Health Sciences Authority (HSA) published a Safety Alert for Finasteride on 30-August-2022. Suicidal ideation is a known...

Sharan Murugan
Sep 1, 20221 min read
Â
Â
